Evidence map›Paper›PMID 38053113›Full record

ArticleBMC public health2023

The Cantabria Cohort, a protocol for a population-based cohort in northern Spain.

Marta Alonso-Peña, Trinidad Dierssen, Maria José Marin, Jessica Alonso-Molero, Inés Gómez-Acebo, Inés Santiuste, Jeffrey V Lazarus, Pascual Sanchez-Juan, Galo Peralta, Javier Crespo and 2 more

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marta Alonso-PeñaValdecilla Research Institute (IDIVAL), Santander, 39011, Spain. malonso@idival.org.
Trinidad DierssenValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Maria José MarinValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Jessica Alonso-MoleroValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Inés Gómez-AceboValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Inés SantiusteValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Jeffrey V LazarusBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Pascual Sanchez-JuanCIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, 28220, Madrid, Spain.
Galo PeraltaValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Javier CrespoValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Marcos Lopez-HoyosValdecilla Research Institute (IDIVAL), Santander, 39011, Spain.
Cantabria Cohort Collaborators

Funding

High Heat and Human Health: Heat Exposure in Restaurant WorkersR21ES039011 · NIEHS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Sarah Febres-Cordero, Daniel Jackson Smith · 2026 to 2026
$468k
F. Hoffmann-La Roche "Stop Fuga de Cerebros" fellowshipFondo de Investigaciones Sanitarias, Instituto de Salud Carlos III PI2201715HORIZON-HLTH-2022-STAYHLTH-02 101095679NIEHS NIH HHS R21 ES039011
6 · The paper itself

Abstract

Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 30,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.

Indexed as

Delivery of Health CareCausalityChronic DiseaseHumansPrognosisSpainBig dataBiobankLifestyleLongitudinal studyPopulation-based cohortPrecision medicineSocio-economic factorsSpain

Identifiers

PMID38053113
PMCPMC10698930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.